Tag: research study
-
Living with breast cancer-related lymphedema in the USA? You may be able to participate in a clinical trial
See if you’re eligible to trial an investigational new medication to treat lymphedema in patients who previously had breast cancer. Read more
-
Clinical trial opportunity for Aussies with breast cancer-related lymphedema
Researchers in Australia are working to understand breast cancer-related lymphedema and study the effectiveness of a new, investigational treatment. Read more
-
Putting Philanthropic Vision into Clinical Action: A conversation with Dr. Sheri and Richard Carreon
“We have the ability to impact millions of individuals in a way that will have generational impact to come.” Read more
-
Getting Technical about Lymphedema Prevention: A conversation with Richard Carreon, Managing Director and CEO of ImpediMed
“The earlier you can detect a chronic disease and effectively treat it, the better the outcomes are going to be.” Read more
-
Research Roundup: Online symptom reporting, detecting cancer with E.coli, and new insights in melanoma treatment
A summary of lymphedema and lymphatic research news from June 5 – 11, 2017. Read more
-
A pill for lymphedema? Talking ubenimex’s potential with Dr. Quan of Eiger BioPharmaceuticals
A conversation with Dr. Joanne Quan, Chief Medical Officer at Eiger BioPharmaceuticals, about the ubenimex trial, the Stanford studies, and the important role patients play in the development of new therapies. Read more
-
Research Roundup: Axillary Nodes, Advocacy, and the Lymphedema Lobby Days
A summary of lymphedema and lymphatic research news from March 18 – 24, 2017. Read more
-
Lymphatic Research News: First patient dosed in pharmaceutical study to treat secondary lymphedema
This summer has been a big one for lymphedema and lymphatic research news! Back in June we talked about the Stanford BioBridge study, where researchers found that surgically implanted nanofibers stimulated growth of new lymph vessels, bypassing lymph blockages and reducing swelling in affected limbs. Now there’s a new study that has the potential to be just as much […] Read more
-
“The most costly thing is doing nothing”: An interview with Dr. Alan T. Hirsch, M.D.
A conversation with Dr. Hirsch is the Director of the Vascular Medicine Program at the University of Minnesota Medical School and co-author of a recent study on the benefits of advanced pneumatic compression devices. Read more